de Silva Nishan's Insider Trades & SAST Disclosures

de Silva Nishan's most recent trade in Cartesian Therapeutics Inc was a trade of 7,800 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.

Share

Note

This is a custom search result for pattern de Silva Nishan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Show

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Cartesian Therapeutics Inc	Nishan de Silva	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	7,800	7,800	-		-	Stock Option (Right to Buy)
Cartesian Therapeutics Inc	Nishan de Silva	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	2,600	8,766 (0%)	0%		0	Common Stock
Selecta Biosciences Inc	de Silva Nishan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	228,000	228,000	-		-	Stock Option (Right to Buy)
Selecta Biosciences Inc	Nishan de Silva	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	178,000	185,000 (0%)	0%		0	Common Stock
Selecta Biosciences Inc	Nishan de Silva	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2023	75,000	75,000	-		-	Stock Option (Right to Buy)
Selecta Biosciences Inc	Nishan de Silva	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2022	40,000	40,000	-		-	Stock Option (Right to Buy)
Selecta Biosciences Inc	Nishan de Silva	Director	Purchase of securities on an exchange or from another person at price $ 2.96 per share.	02 Dec 2021	7,000	7,000 (0%)	0%	3.0	20,723	Common Stock
Selecta Biosciences Inc	Nishan de Silva	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2021	80,000	80,000	-		-	Stock Option (Right to Buy)

Showing 1 to 8 of 8 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades